Logo Image
|Webcasts|December 11, 2019

Managing Signals in the Modern Pharmacovigilance Landscape

Recent research has emboldened the industry as it moves from traditional to hybrid studies with the promise of greater patient participation and patient access – despite this risk to overall study quality data was cited as the number one concern with decentralized trials. How can these risks be mitigated against? Live: Wednesday, Dec. 11, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET On demand available after airing until Dec. 11, 2020. Register free

Register free: http://www.appliedclinicaltrialsonline.com/act_w/landscape

Event Overview: 

Signal management teams are entering a new world of pharmacovigilance, one where more big data sources are being used for signal detection and it’s becoming harder to sift through all that data manually. In this webcast, Oracle Health Sciences will review the best practices and new technologies for managing safety signals compliantly and efficiently, whether you’re part of a large organization that’s looking to improve existing processes or a small team that’s just starting to put a system in place. These include:

  • User experience: making signals understandable and actionable for signal evaluators

  • Signal documentation: traceability of decisions and actions in a regulatory inspection

  • Lifecycle signal management: starting signaling activities during clinical trials and transitioning to post-marketing surveillance

  • Signal detection methods: different approaches for different data sets

  • Data mining algorithms: reducing the number of false positives and thus work for the signal evaluation tea

  • Multimodal signal detection: aggregating signal statistics across multiple big data sets

  • Neural signal detection: using artificial intelligence and deep learning to find new risks

  • Predictive signal detection: cutting-edge research into future methodologies

Key Learning Objectives:

  • Best Practices in Signal Management

  • Insure compliance and efficiency

  • Understand the true power of AI, Predictive Analytics and Data mining

Speaker: Michael Braun-Boghos, Senior Director, Safety Strategy, Oracle Health Sciences

Time and date: Wednesday, Dec. 11, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET

On demand available after airing until Dec. 11, 2020.

Sponsor: Oracle Health Sciences

Register free: http://www.appliedclinicaltrialsonline.com/act_w/landscape

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more